CASTRATION RESISTANT PROSTATE CANCER (CRPC)
Clinical trials for CASTRATION RESISTANT PROSTATE CANCER (CRPC) explained in plain language.
Never miss a new study
Get alerted when new CASTRATION RESISTANT PROSTATE CANCER (CRPC) trials appear
Sign up with your email to follow new studies for CASTRATION RESISTANT PROSTATE CANCER (CRPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heated cell therapy targets prostate cancer tumors
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called ACT#001, for men with advanced prostate cancer that no longer responds to hormone therapy. The therapy involves collecting a patient's own immune cells, genetically modifying them to target a protein on pr…
Matched conditions: CASTRATION RESISTANT PROSTATE CANCER (CRPC)
Phase: EARLY_PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
New imaging agent seeks to light up hidden cancer
Diagnosis Not yet recruitingThis early-stage study is testing a new imaging agent called 111In-ABD147 to see if it can detect metastatic cancer in patients with solid tumors. The agent is designed to attach to a protein called DLL3, which is often found on certain cancer cells. The main goals are to see if …
Matched conditions: CASTRATION RESISTANT PROSTATE CANCER (CRPC)
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC